Thomas J. Hudson

Companies

• AbbVieSVP, R&D and CSO Jul 9, 2019 to Mar 1, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• AbbVie ABBV107,267 shares²$30.4M at $283.40Feb 28, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 28, 2024Shares withheld for tax 20,634 shares at $178.99 of AbbVie²
• Feb 15, 2024Granted 5,348 shares of AbbVie³
• Feb 15, 2024Granted 5,350 shares of AbbVie³
• Feb 15, 2024Granted 7,552 shares of AbbVie³
• Feb 15, 2024Granted 28,322 shares of AbbVie³
• Feb 28, 2023Shares withheld for tax 27,922 shares at $154.28 of AbbVie⁴
• Feb 16, 2023Granted 5,350 shares of AbbVie⁵
• Feb 16, 2023Granted 7,552 shares of AbbVie⁵
• Feb 16, 2023Granted 9,481 shares of AbbVie⁵
• Feb 16, 2023Granted 40,640 shares of AbbVie⁵
• Feb 25, 2022Shares withheld for tax 13,408 shares at $149.54 of AbbVie⁶
• Feb 17, 2022Granted 6,609 shares of AbbVie⁷
• Feb 17, 2022Granted 9,483 shares of AbbVie⁷
• Feb 17, 2022Granted 2,530 shares of AbbVie⁷
• Feb 17, 2022Granted 11,642 shares of AbbVie⁷